Publication Ethics and Malpractice Statement

Publication Ethics and Malpractice Statement

Aksara Health
Journal of Equity and Innovation in Resource-Limited Settings
 

Aksara Health: Journal of Equity and Innovation in Resource-Limited Settings is committed to maintaining the highest standards of integrity, transparency, accountability, fairness, and ethical conduct throughout the scholarly publishing process.

These principles apply to authors, reviewers, editors, editorial board members, journal staff, and the publisher. The journal takes allegations of research or publication misconduct seriously and will evaluate concerns fairly, confidentially, and in accordance with recognized standards of scholarly publishing.

1. Responsibilities of Editors

Editors are responsible for ensuring the integrity, fairness, quality, and independence of the editorial process. Manuscripts will be evaluated primarily on their scientific merit, methodological quality, relevance to the journal's scope, originality, ethical integrity, and clarity.

Editors are expected to:

  • make editorial decisions independently of commercial, institutional, political, personal, or other inappropriate influence;
  • evaluate manuscripts without discrimination based on nationality, ethnicity, race, sex, gender, religion, institutional affiliation, socioeconomic status, disability, political belief, or other irrelevant characteristics;
  • protect the confidentiality of submitted manuscripts and associated correspondence;
  • select reviewers with appropriate expertise and without significant competing interests;
  • recuse themselves from manuscripts for which they have a relevant conflict of interest;
  • respond appropriately to allegations of misconduct before and after publication; and
  • preserve the integrity of the scholarly record through appropriate corrections, expressions of concern, or retractions when necessary.

2. Responsibilities of Peer Reviewers

Peer reviewers play an essential role in maintaining the scientific quality and integrity of the journal. Reviews should be objective, constructive, evidence-based, respectful, and completed within the agreed time.

  • Reviewers must maintain the confidentiality of submitted manuscripts.
  • Unpublished information obtained through peer review must not be used for personal, academic, financial, or competitive advantage.
  • Reviewers should disclose relevant conflicts of interest and decline review when impartial assessment cannot reasonably be assured.
  • Personal criticism, discriminatory comments, hostile language, and unsupported allegations are unacceptable.
  • Reviewers should identify significant methodological problems, unsupported conclusions, relevant missing literature, suspected plagiarism, data concerns, or ethical issues when detected.
  • Reviewers must not attempt to manipulate citations by requesting unnecessary citations for personal benefit or to artificially increase citations to particular authors, journals, or publications.

3. Responsibilities of Authors

Authors are responsible for the integrity, accuracy, originality, and transparency of their submitted work.

By submitting a manuscript to Aksara Health, authors confirm that:

  • the work is original and accurately represents the research performed;
  • data have not been fabricated, falsified, selectively manipulated, or intentionally misrepresented;
  • all individuals qualifying for authorship have been appropriately listed;
  • all listed authors have reviewed and approved the submitted version;
  • relevant funding, competing interests, ethical approval, informed consent, and use of AI-assisted technologies have been disclosed where applicable;
  • the manuscript is not simultaneously under consideration by another journal; and
  • appropriate permissions have been obtained for copyrighted or otherwise protected material reproduced in the manuscript.

4. Authorship and Contributorship

Authorship should reflect substantial intellectual contribution and accountability for the published work. Aksara Health applies the general authorship principles recommended by the ICMJE.

Authors should have:

  1. made a substantial contribution to the conception or design of the work, or to the acquisition, analysis, or interpretation of data;
  2. participated in drafting the manuscript or critically revising it for important intellectual content;
  3. approved the final version to be published; and
  4. agreed to be accountable for the integrity and accuracy of the work.

Individuals who contribute to the work but do not meet authorship criteria should be acknowledged rather than listed as authors. Guest, gift, honorary, and ghost authorship are unacceptable.

Requests to add, remove, or reorder authors after submission must include a valid explanation and documented agreement from all affected authors. Changes after acceptance or publication will be considered only in exceptional circumstances and may require institutional clarification.

5. Equitable Global Health Research and Local Collaboration

Consistent with the mission of Aksara Health, research involving communities, institutions, data, or populations in resource-limited and underserved settings should promote equitable and respectful collaboration.

Where research is conducted in a particular country or community, meaningful participation of appropriately qualified local researchers should be considered in study design, implementation, interpretation, and authorship. Exclusion of local contributors who meet recognized authorship criteria is inconsistent with the journal's commitment to health equity and responsible global research.

6. Originality, Plagiarism and Proper Attribution

Manuscripts must represent original scholarly work. Authors must appropriately acknowledge the ideas, data, methods, figures, tables, and words of others. Verbatim material must be quoted or otherwise clearly identified and properly cited.

Plagiarism, including direct copying, inappropriate paraphrasing, unattributed use of another person's work, and substantial self-plagiarism or undisclosed text recycling, may result in rejection or post-publication action.

Similarity-detection software may be used as an editorial screening tool. Similarity percentages alone will not determine misconduct; potential overlap will be assessed in context by the editorial team.

7. Duplicate Submission, Redundant Publication and Prior Publication

A manuscript must not be submitted simultaneously to more than one journal. Authors must disclose related manuscripts, previous reports, conference papers, preprints, datasets, or publications that substantially overlap with the submitted work.

Redundant or duplicate publication without appropriate disclosure and justification is unacceptable. Legitimate secondary publication may be considered only when clearly identified, appropriately authorized, and consistent with recognized publication standards.

Posting a legitimate preprint does not automatically disqualify a manuscript. Authors must disclose the existence and location of any relevant preprint at submission.

8. Research and Publication Misconduct

Research and publication misconduct may include, but is not limited to:

  • fabrication or falsification of data;
  • plagiarism or substantial unattributed copying;
  • inappropriate manipulation of images or results;
  • duplicate or redundant publication;
  • undeclared conflicts of interest;
  • authorship manipulation;
  • peer-review manipulation;
  • citation manipulation;
  • fabricated references or reviewers;
  • misrepresentation of ethical approval or informed consent;
  • misuse of confidential information; and
  • other deliberate actions that compromise the integrity of the scholarly record.

Suspected misconduct may be investigated in accordance with appropriate editorial procedures. When necessary, the journal may contact authors, institutions, ethics committees, funders, or other relevant bodies.

9. Research Involving Human Participants

Research involving human participants, identifiable human biological materials, or identifiable personal data must have been conducted in accordance with applicable ethical and legal requirements and internationally recognized principles for human research.

Authors should obtain approval from an appropriate independent ethics committee, institutional review board, or equivalent authority before commencing research when such approval is required.

Manuscripts should state the name of the approving ethics body and, where applicable, the approval or reference number. The editorial office may request documentation of ethical approval.

Research involving human participants should be consistent with the principles of the current World Medical Association Declaration of Helsinki and applicable national or institutional requirements.

10. Informed Consent, Patient Privacy and Case Reports

Informed consent for participation must be obtained when required by the study design, ethics approval, or applicable regulation.

Identifiable patient information, photographs, images, pedigrees, videos, or other potentially identifying material must not be published without appropriate consent for publication unless a lawful and ethically justified exception applies.

Authors of case reports and case series involving identifiable individuals should obtain written informed consent for publication from the patient or an appropriate legally authorized representative. Unnecessary identifying information should be removed.

11. Vulnerable and Underserved Populations

Research involving children, people with impaired decision-making capacity, displaced populations, economically disadvantaged groups, marginalized communities, Indigenous populations, or other potentially vulnerable groups requires particular attention to informed consent, risk minimization, fair participant selection, privacy, cultural context, and avoidance of exploitation.

The scientific and social value of the research should be clearly justified, particularly when risks or burdens are disproportionately borne by vulnerable or resource-constrained populations.

12. Animal Research

Studies involving animals must comply with relevant institutional, national, and internationally recognized standards for the ethical use and welfare of animals.

Authors should report approval from the relevant animal ethics committee or institutional authority and provide the approval number where applicable.

Researchers are expected to minimize animal suffering and unnecessary use and to apply appropriate principles of replacement, reduction, and refinement. Animal studies should be reported using appropriate reporting standards, such as the ARRIVE guidelines where applicable.

13. Clinical Trial Registration

Prospective clinical trials should be registered in an appropriate publicly accessible clinical trial registry at or before the enrollment or consent of the first participant, consistent with applicable international standards.

The trial registration number and registry should be reported in the manuscript. Authors must disclose discrepancies between registered protocols, trial outcomes, and the submitted report and provide appropriate explanations.

14. Reporting Standards and Research Transparency

Authors should use appropriate reporting guidelines for their study design whenever available. Examples include:

CONSORT – Randomized Trials STROBE – Observational Studies PRISMA – Systematic Reviews STARD – Diagnostic Studies CARE – Case Reports ARRIVE – Animal Research COREQ / SRQR – Qualitative Research SQUIRE – Quality Improvement CHEERS – Economic Evaluations

Editors may request submission of relevant reporting checklists or flow diagrams when appropriate.

15. Data Integrity, Availability and Reproducibility

Authors are responsible for maintaining accurate and complete research records. Data should be collected, stored, analyzed, and reported in ways that preserve research integrity and comply with applicable ethical, legal, institutional, and privacy requirements.

Authors may be asked to provide underlying data, analytical code, protocols, statistical outputs, original images, or other research materials when required to assess the integrity or reproducibility of the work.

Where ethically and legally possible, authors are encouraged to make research data and analytical materials available through appropriate repositories and to include a clear Data Availability Statement.

Restrictions on data sharing due to participant privacy, consent, confidentiality, intellectual property, contractual obligations, or legal requirements should be transparently explained.

16. Image Integrity and Digital Manipulation

Images used as scientific evidence must accurately represent the original data. Adjustments to brightness, contrast, color balance, or other properties should be applied uniformly and must not obscure, eliminate, introduce, or misrepresent scientifically relevant information.

Selective enhancement, deletion, duplication, relocation, splicing, or fabrication of image features is unacceptable unless scientifically justified, explicitly described, and clearly identified.

The journal may request original, unprocessed image files when questions about image integrity arise.

17. Conflicts of Interest and Competing Interests

Authors, reviewers, editors, and editorial staff must disclose financial and non-financial interests that could reasonably be perceived to influence their work, assessment, or editorial judgment.

Relevant interests may include employment, consultancy, honoraria, grants, patents, stock ownership, advisory roles, personal relationships, professional competition, academic rivalry, institutional interests, or strongly held intellectual commitments.

The existence of a competing interest does not automatically prevent publication. Transparent disclosure enables editors and readers to evaluate its potential relevance.

18. Funding and Role of Sponsors

Authors must disclose all relevant sources of financial or material support. The role of sponsors or funders in study design, data collection, analysis, interpretation, manuscript preparation, and the decision to submit for publication should be stated where relevant.

Funders and sponsors must not improperly restrict authors' access to data, suppress legitimate findings, or interfere with independent editorial decisions.

19. Artificial Intelligence and AI-Assisted Technologies

Artificial intelligence systems, generative AI tools, large language models, chatbots, or similar technologies cannot be listed as authors because they cannot assume responsibility or accountability for scholarly work.

Authors remain fully responsible for all submitted content, including material generated or modified using AI-assisted technologies. Substantive use of AI should be transparently disclosed, including the technology used and its purpose.

When AI, machine learning, deep learning, computer vision, or related technologies constitute part of the research methodology, their use must be described in sufficient methodological detail to permit scientific assessment and reproducibility.

Editors and reviewers must not upload confidential submitted manuscripts, peer-review material, or unpublished research into AI systems where confidentiality cannot be assured unless explicitly authorized by the journal and the authors.

AI-generated recommendations must not replace independent human editorial judgment. Human authors, reviewers, and editors remain accountable for scientific accuracy, ethical compliance, confidentiality, and editorial decisions.

20. Peer Review Integrity

Aksara Health is committed to an independent and academically rigorous peer-review process. Attempts to manipulate peer review are considered serious publication misconduct.

Prohibited practices include creating false reviewer identities, submitting fabricated reviewer accounts, impersonating researchers, interfering with reviewer selection, coercing reviewers, manipulating review reports, or organizing inappropriate reciprocal review arrangements.

21. Submissions from Editors and Editorial Board Members

Editors and editorial board members are not prohibited from submitting manuscripts to Aksara Health. However, they must not participate in the editorial assessment, reviewer selection, peer review, or decision-making process for their own manuscripts or manuscripts in which they have a significant competing interest.

Such submissions will be handled independently by another qualified editor without a relevant conflict of interest. The journal will not provide preferential treatment based on an author's editorial position or relationship with the publisher.

22. Editorial Independence

Editorial decisions are made on the basis of scholarly merit and are independent of inappropriate commercial, financial, institutional, or publisher influence.

Aksara Sains Banua, as publisher, supports the editorial independence of Aksara Health and does not determine acceptance or rejection of individual manuscripts for commercial or personal reasons.

23. Corrections, Retractions and Expressions of Concern

Aksara Health is committed to maintaining an accurate and trustworthy scholarly record. Post-publication issues will be addressed according to the nature and severity of the problem.

Corrections may be issued when an error affects the accuracy or interpretation of a publication but does not invalidate its main findings.

Retractions may be considered when findings are unreliable because of major error or misconduct, when plagiarism or substantial redundant publication is confirmed, when research is unethical, when data or material were used without appropriate authorization, or when other serious problems undermine the reliability or legitimacy of the article.

Expressions of Concern may be issued when serious questions have arisen but an investigation remains incomplete or evidence is not yet sufficient for a final decision.

Retraction and correction notices will be linked to the affected article and will explain the reason for the editorial action as clearly and objectively as reasonably possible.

24. Complaints and Appeals

Authors, reviewers, readers, and other stakeholders may raise concerns or complaints about editorial procedures, publication ethics, reviewer conduct, editorial decisions, or published material.

Appeals against editorial decisions should identify the manuscript concerned, explain the basis of the appeal, and provide a clear scientific or procedural justification. Disagreement with an editorial decision alone is not sufficient grounds for reconsideration.

Where appropriate, complaints and appeals will be reviewed by an editor who was not directly responsible for the disputed decision.

25. Allegations and Whistleblowers

Concerns regarding possible misconduct will be taken seriously regardless of whether they are raised before or after publication.

Individuals raising concerns should provide sufficient evidence or information to permit reasonable assessment. The journal will seek to protect confidentiality where appropriate and will not dismiss substantiated concerns solely because the complainant wishes to remain anonymous.

Allegations should be made in good faith. Deliberately false, malicious, or harassing allegations are themselves inconsistent with responsible scholarly conduct.

26. Post-Publication Discussion

Scientific discussion does not end at publication. Readers are encouraged to communicate substantive concerns, corrections, methodological questions, or evidence relevant to published articles.

Valid post-publication concerns will be considered objectively and may lead to author clarification, correction, editorial notice, expression of concern, retraction, or other appropriate action.

27. Possible Actions in Cases of Misconduct

Depending on the nature, evidence, and severity of a confirmed or credible ethical concern, Aksara Health may take one or more appropriate actions, including:

  • requesting clarification or supporting documentation;
  • rejecting a manuscript;
  • terminating peer review;
  • issuing a correction or editorial notice;
  • publishing an expression of concern;
  • retracting a published article;
  • contacting relevant institutions, ethics committees, or funders;
  • restricting future submissions in serious cases where justified; or
  • taking other proportionate measures necessary to protect the scholarly record.

Editorial action will be based on available evidence and will seek to be proportionate, fair, and consistent with recognized publication-ethics guidance.

28. Copyright, Licensing and Intellectual Property

Authors must respect copyright, intellectual property, database rights, confidentiality, and permissions relating to material included in their manuscripts.

Unless otherwise stated, published scholarly content in Aksara Health is distributed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0) .

Licensing terms do not override participant privacy, confidentiality, third-party copyright, database restrictions, or other rights that may apply to particular content.

Our Commitment
Scientific integrity, ethical responsibility, transparency, and equitable scholarship are fundamental principles of Aksara Health.
Editorial decisions are guided by the quality and integrity of the science, not by commercial interest, institutional status, nationality, or personal relationships.

Ethics and Publication Integrity Contact

Questions, concerns, appeals, or allegations relating to publication ethics may be directed to:

Aksara Health: Journal of Equity and Innovation in Resource-Limited Settings
Published by Aksara Sains Banua
Indonesia

Official Email: [insert official journal email]

Last updated: September 2026